| Name | Title | Contact Details |
|---|
NeoVista Inc. is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Kurbo Health provides the first mobile coaching solution that is designed specifically to help children and families lose weight and develop smarter eating choices. It is based on one of the most advanced weight-management programs from Stanford University, and proven effective in helping kids lose weight and create healthy habits. Kurbo kids and families receive weekly video consults and goal-setting with a trained professional coach via Skype or FaceTime, a mobile app designed to help them track food and exercise on their smartphone, and daily support from a team of experts through emails, text messages, and in-app games and videos. The company has offices in San Francisco and Palo Alto.
GlySens Incorporated is a privately held corporation devoted to developing the world`s first truly long term continuous glucose monitoring system. Our goal: to enable easy, unobtrusive, worry-free diabetes control that empowers users by providing the information they need to optimize care, while freeing them to live life on their own terms.
Healthy Heart Sleep Programs is a Brockton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnpod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 100,000 users across the globe rely on Insulet`s Omnipod Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit: www.insulet.com, www.myomnipod.com and https://www.omnipodeurope.com.* *Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.